About the speaker

Dr. Susan Rosencrance currently serves as the Director for the Office of Lifecycle Drug Products in the Office of Pharmaceutical Quality (OPQ).  In this capacity, she directs procedures and processes for evaluating and assessing drug product quality during the lifecycle of both brand name and generic drug products.  Prior to joining the FDA, Susan worked at Merck & Co.'s R&D Laboratories in Rahway, New Jersey.  She joined the Office of Generic Drugs (OGD) in 1991 and spent the majority of her tenure in CDER working on generic drug products.  She held various roles within OGD including senior chemistry reviewer, team leader, deputy division director, and OGD Deputy Director for Chemistry.  Susan also served as the Deputy Director for Generic Drug Chemistry in the Office of Pharmaceutical Science prior to the formation of OPQ.  Susan holds a Ph.D. in Chemistry from American University and completed her dissertation research at the NIH Laboratory of Biophysical Chemistry conducting a molecular dynamics study on hydrophobic interactions in alpha-helical coiled coils found in proteins.  She received her bachelor’s degree in Biochemistry from Hood College and also completed studies at the University of Strasbourg in Strasbourg, France in the Institute Internationale D’Etudes Française – Université Louis-Pasteur.